Details zur Publikation |
Kategorie | Textpublikation |
Referenztyp | Zeitschriften |
DOI | 10.1002/cmdc.202100732 |
Lizenz ![]() |
|
Titel (primär) | Andrographolide derivatives target the KEAP1/NRF2 axis and possess potent anti-SARS-CoV-2 activity |
Autor | Schulte, B.; König, M.; Escher, B.I.
![]() |
Quelle | ChemMedChem |
Erscheinungsjahr | 2022 |
Department | ZELLTOX |
Band/Volume | 17 |
Heft | 5 |
Seite von | e202100732 |
Sprache | englisch |
Topic | T9 Healthy Planet |
Supplements | https://chemistry-europe.onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fcmdc.202100732&file=cmdc202100732-sup-0001-misc_information.pdf |
Keywords | SARS-CoV-2; andrographolide; KEAP1/NRF2; natural products; medicinal chemistry |
Abstract | Naturally occurring compounds represent a vast pool of pharmacologically active entities. One of such compounds is andrographolide, which is endowed with many beneficial properties, including the activity against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). To initiate a drug repurposing or hit optimization campaign, it is imperative to unravel the primary mechanism(s) of the antiviral action of andrographolide. Here, we showed by means of a reporter gene assay that andrographolide exerts its anti-SARS-CoV-2 effects by inhibiting the interaction between Kelch-like ECH-associated protein 1 (KEAP1) and nuclear factor erythroid 2-related factor 2 (NRF2) causing NRF2 upregulation. Moreover, we demonstrated that subtle structural modifications of andrographolide could lead to derivatives with stronger on-target activities and improved physicochemical properties. Our results indicate that further optimization of this structural class is warranted to develop novel COVID-19 therapies. |
dauerhafte UFZ-Verlinkung | https://www.ufz.de/index.php?en=20939&ufzPublicationIdentifier=25731 |
Schulte, B., König, M., Escher, B.I., Wittenburg, S., Proj, M., Wolf, V., Lemke, C., Schnakenburg, G., Sosič, I., Streeck, H., Müller, C.E., Gütschow, M., Steinebach, C. (2022): Andrographolide derivatives target the KEAP1/NRF2 axis and possess potent anti-SARS-CoV-2 activity ChemMedChem 17 (5), e202100732 10.1002/cmdc.202100732 |